Caldwell Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$84.3K Hold
660
0.01% 426
2025
Q4
$80.5K Hold
660
0.01% 417
2025
Q3
$66.1K Hold
660
0.01% 435
2025
Q2
$54.7K Hold
660
0.01% 452
2025
Q1
$53.5K Hold
660
0.01% 457
2024
Q4
$59.4K Hold
660
0.01% 441
2024
Q3
$65.2K Hold
660
0.01% 431
2024
Q2
$61.2K Sell
660
-55
-8% -$4.93K 0.01% 433
2024
Q1
$67.8K Hold
715
0.01% 423
2023
Q4
$63.8K Sell
715
-405
-36% -$30.1K 0.01% 417
2023
Q3
$81.8K Hold
1,120
0.01% 374
2023
Q2
$93.2K Hold
1,120
0.01% 365
2023
Q1
$85.4K Hold
1,120
0.01% 365
2022
Q4
$93K Sell
1,120
-150
-12% -$12.1K 0.01% 350
2022
Q3
$101K Sell
1,270
-20
-2% -$1.69K 0.02% 343
2022
Q2
$95.8K Hold
1,290
0.01% 359
2022
Q1
$116K Sell
1,290
-100
-7% -$9.23K 0.01% 351
2021
Q4
$156K Hold
1,390
0.02% 318
2021
Q3
$175K Sell
1,390
-150
-10% -$19.3K 0.02% 293
2021
Q2
$209K Buy
1,540
+20
+1% +$2.63K 0.03% 272
2021
Q1
$206K Hold
1,520
0.03% 267
2020
Q4
$214K Hold
1,520
0.03% 248
2020
Q3
$169K Buy
1,520
+160
+12% +$17.9K 0.03% 264
2020
Q2
$152K Buy
1,360
+20
+1% +$1.97K 0.03% 276
2020
Q1
$104K Buy
1,340
+300
+29% +$26.6K 0.02% 317
2019
Q4
$98.9K Buy
+1,040
New +$90K 0.02% 364

Other funds holding XBI

Caldwell Trust's XBI Position: Q1 2026 in Review

Caldwell Trust held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 660 shares worth $84.3K. The position accounts for 0.01% of the portfolio, ranked #426.

Caldwell Trust first reported a position in XBI in Q4 2019 and has held it in 26 quarters since. The position peaked at $214K in Q4 2020. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Caldwell Trust held 660 shares of State Street SPDR S&P Biotech ETF worth $84.3K as of Q1 2026.
  • Caldwell Trust left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Caldwell Trust's portfolio in Q1 2026, its #426 holding.
  • Caldwell Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 26 quarters since.
  • Caldwell Trust's State Street SPDR S&P Biotech ETF position peaked at $214K in Q4 2020.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.